Litt’s Drug profile for Ozenoxacin


BreastfeedingPediatric
  • FDA Approval Date: 12/11/2017
  • Clinically important, potentially hazardous interactions with:
    None known
  • Pregnancy: No data available to inform drug-associated risk

For topical use only.

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric